Send the following on WhatsApp
Continue to ChatCirculating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. - https://avesis.cu.edu.tr/yayin/352818fe-aadc-4722-864b-19cc2c91d7ba/circulating-interleukin-18-il-18-is-a-predictor-of-response-to-gemcitabine-based-chemotherapy-in-patients-with-pancreatic-adenocarcinoma